Nanoconstructs for the efficient delivery of siRNA molecules against Aquaporin-1 for anti-angiogenic therapies

被引:0
|
作者
Stigliano, Cinzia [1 ]
Ananta, Jeyarama [1 ]
Acharya, Swetadrinadha [1 ]
Mackeyev, Yuri [2 ]
Wilson, Lon [2 ]
Nicchia, Grazia Paola [3 ]
Svelto, Maria [3 ]
Decuzzi, Paolo [1 ]
机构
[1] Methodist Hosp, Res Inst, Houston, TX 77030 USA
[2] Rice Univ, Houston, TX USA
[3] Univ Bari, Bari, Italy
关键词
D O I
10.1158/1538-7445.AM2012-2887
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2887
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Protection against light-induced retinal degeneration via dual anti-inflammatory and anti-angiogenic functions of thrombospondin-1
    Ju, Yahan
    Tang, Zhimin
    Dai, Xiaochan
    Gao, Huiqin
    Zhang, Jing
    Liu, Yan
    Yang, Yanan
    Ni, Ni
    Zhang, Dandan
    Wang, Yuyao
    Sun, Na
    Yin, Luqiao
    Luo, Min
    Zhang, Jianhua
    Gu, Ping
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (09) : 1938 - 1961
  • [22] Effective transscleral delivery of two retinal anti-angiogenic molecules -: Carboxyamido-triazole (CAI) and 2-methoxyestradiol (2ME2)
    Cruysberg, LPJ
    Franklin, AJ
    Sanders, J
    Self, C
    Yuan, P
    Csaky, KG
    Robinson, MR
    Kohn, EC
    Edelhauser, HF
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2005, 25 (08): : 1022 - 1031
  • [23] ICAM-1-Targeted, Lcn2 siRNA-Encapsulating Liposomes are Potent Anti-angiogenic Agents for Triple Negative Breast Cancer
    Guo, Peng
    Yang, Jiang
    Jia, Di
    Moses, Marsha A.
    Auguste, Debra T.
    THERANOSTICS, 2016, 6 (01): : 1 - 13
  • [24] FGFR1 is associated with c-MYC and proangiogenic molecules in metastatic renal cell carcinoma under anti-angiogenic therapy
    Park, Jee Young
    Kim, Pil-Jong
    Shin, Su-Jin
    Lee, Jae-Lyun
    Cho, Yong Mee
    Go, Heounjeong
    HISTOPATHOLOGY, 2020, 76 (06) : 838 - 851
  • [25] An ICAM-1-targeted, Lcn2 siRNA-encapsulating liposome as a potent anti-angiogenic agent for triple-negative breast cancer
    Guo, Peng
    Yang, Jiang
    Moses, Marsha
    Auguste, Debra
    CANCER RESEARCH, 2015, 75
  • [26] Novel anti-angiogenic gene therapy by cis-trans element decoy system against Sp1 transactivation.
    Ishibashi, H
    Imai, M
    Onimaru, M
    Matsuura, S
    Shirasuna, K
    ORAL ONCOLOGY, 2005, 1 (01) : 190 - 191
  • [27] Synergistic Anti-Angiogenic Effects Using Peptide-Based Combinatorial Delivery of siRNAs Targeting VEGFA, VEGFR1, and Endoglin Genes
    Egorova, Anna A.
    Shtykalova, Sofia, V
    Maretina, Marianna A.
    Sokolov, Dmitry, I
    Selkov, Sergei A.
    Baranov, Vladislav S.
    Kiselev, Anton, V
    PHARMACEUTICS, 2019, 11 (06)
  • [28] Combat Against Gynecological Cancers with Blood Vessels as Entry Point: Anti-Angiogenic Drugs, Clinical Trials and Pre-Clinical Nano-Delivery Platforms
    Yang, Shan
    Fei, Weidong
    Zhao, Yunchun
    Wang, Fengmei
    Ye, Yiqing
    Wang, Fenfen
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2023, 18 : 3035 - 3046
  • [29] Polymeric Vector-Mediated Targeted Delivery of Anti-PAK1 siRNA to Macrophages for Efficient Atherosclerosis Treatment
    Wu, Teng
    Xiao, Hong
    Lu, Liejing
    Chen, Yali
    Wang, Yong
    Xia, Wenhao
    Long, Ming
    Tao, Jun
    Shen, Jun
    Shuai, Xintao
    ACS BIOMATERIALS SCIENCE & ENGINEERING, 2019, 5 (09) : 4455 - 4462
  • [30] Anti-angiogenic Mechanism of IPS-05002, a Novel Antagonist against Integrin α5β1, Determined by ProteoChip-based Antibody Array
    Kim, Min-A
    Kang, In-Cheol
    BIOCHIP JOURNAL, 2016, 10 (03) : 174 - 181